Two hypercholesterolemic mouse models, the apo-E-deficient mouse (Apoe Ϫ/Ϫ ) and the LDL receptor-deficient mouse (Ldlr Ϫ/Ϫ ), have been used extensively as animal models of atherogenesis. Total plasma cholesterol levels in chow-fed Apoe Ϫ/Ϫ mice are much higher than in Ldlr Ϫ/Ϫ mice. In a recent study, we managed to even-up the cholesterol levels in Apoe Ϫ/Ϫ mice and Ldlr Ϫ/Ϫ mice by making both models homozygous for the Apob 100 (apo B-100 -only) allele. On a chow diet, apo-E-deficient apo B-100 -only mice (Apoe Ϫ/Ϫ Apob 100/100 ) and LDL receptor-deficient apo B-100 -only mice (Ldlr Ϫ/Ϫ Apob 100/100 ) had similar total plasma cholesterol levels (Ϸ300 mg/dL). The plasma of Ldlr Ϫ/Ϫ Apob 100/100 mice contained large numbers of small lipoproteins, whereas the plasma of Apoe Ϫ/Ϫ Apob 100/100 mice contained much lower levels of much larger lipoproteins. Interestingly, the Ldlr Ϫ/Ϫ Apob 100/100 mice developed far more extensive atherosclerotic lesions than the Apoe Ϫ/Ϫ Apob 100/100 mice. The finding of substantially more atherosclerosis in Ldlr Ϫ/Ϫ Apob 100/100 mice than in Apoe Ϫ/Ϫ Apob 100/100 mice, despite nearly identical cholesterol levels, suggests that large numbers of small apo B-100 -containing lipoproteins are far more atherogenic than lower numbers of large apo B-100 -containing lipoproteins.
T wo hypercholesterolemic mouse models, the apo Edeficient mouse (Apoe Ϫ/Ϫ ) 1-3 and the LDL receptordeficient mouse (Ldlr Ϫ/Ϫ ), 4 have been used extensively to study atherogenesis. On a chow diet, Apoe Ϫ/Ϫ mice have total cholesterol levels of 400 to 500 mg/dL due mainly to the accumulation of VLDL remnants and develop severe atherosclerotic lesions throughout the arterial tree. 5, 6 Chow-fed Ldlr Ϫ/Ϫ mice have mildly increased plasma cholesterol levels (175 to 225 mg/dL) from an accumulation of LDL and develop only minimal atherosclerotic lesions in the proximal aortic root. 4 Apo B-48 is the predominant apolipoprotein in the VLDL remnants of Apoe Ϫ/Ϫ mice, whereas apo B-100 predominates in the LDL of Ldlr Ϫ/Ϫ mice. 7 Both the Apoe Ϫ/Ϫ and Ldlr Ϫ/Ϫ mice have been a boon to atherosclerosis research, principally because they have made it possible to investigate a multitude of genetic influences on atherogenesis and to do so without resorting to diets containing high levels of fats and cholesterol. Nevertheless, reservations about these models are occasionally voiced at scientific meetings. In the case of chow-fed Ldlr Ϫ/Ϫ mice, there is frustration about the minimal amount of atherosclerotic lesions, even after 9 to 12 months. In the case of the Apoe Ϫ/Ϫ mice, concerns are voiced about the very high ("nonphysiological") plasma cholesterol levels. One also hears concerns about using an animal model in which most of the cholesterol is carried in apo B-48 -containing VLDL and chylomicron remnants, given that most humans with atherosclerosis have high plasma levels of apo B-100 -containing LDL.
In discussions of the pros and cons of Apoe Ϫ/Ϫ and Ldlr Ϫ/Ϫ mice, one occasionally hears speculation about whether the lipoproteins in the 2 animal models are intrinsically different in their capacities to promote atherosclerosis. Some investigators are convinced that the VLDL remnants in Apoe Ϫ/Ϫ mice are particularly atherogenic, given the dramatic and severe atherosclerotic lesions in that model. Others have maintained that such speculation is pointless because the total plasma cholesterol levels in Apoe Ϫ/Ϫ mice are so much higher than in Ldlr Ϫ/Ϫ mice.
Chow-Fed Apoe ؊/؊ and Ldlr ؊/؊ Mice With Similar Total Cholesterol Levels
In a recent study, 8 we managed to even up the cholesterol levels in chow-fed Apoe Ϫ/Ϫ mice and Ldlr Ϫ/Ϫ mice. We did so by making both mouse models homozygous for the Apob 100 ("apo B-100 -only") allele, 9 which ameliorates the hypercholesterolemia in the setting of Apoe deficiency 9 but worsens it in the setting of Ldlr deficiency. 8, 10 Remarkably, the total plasma cholesterol levels in apo B-100 -only, apo E-deficient mice (Apoe Ϫ/Ϫ Apob 100/100 and apo B-100 -only, LDL receptor-deficient mice (Ldlr Ϫ/Ϫ Apob 100/100 were virtually identical (275 to 325 mg/dL). 8 HDL cholesterol levels were also indistinguishable ( Figure 1 ). Although the total plasma cholesterol levels in Apoe Ϫ/Ϫ Apob 100/100 and Ldlr Ϫ/Ϫ Apob 100/100 mice were virtually identical, the sizes of lipoproteins in the 2 models were not. 8 Nearly all of the cholesterol in the plasma of Apoe Ϫ/Ϫ Apob 100/100 mice was in the VLDL fraction, whereas nearly all of the cholesterol in the Ldlr Ϫ/Ϫ Apob 100/100 mice was in LDL (Figure 1 ). When we quantified the sizes of the lipoproteins, we found that the lipoproteins in the plasma of Apoe Ϫ/Ϫ Apob 100/100 mice were immense (mean size of 63 nm), whereas the vast majority of the lipoproteins in Ldlr Ϫ/Ϫ Apob 100/100 mice were small (mean size of only 24 nm). There was almost no overlap in the sizes of the apo B-containing lipoproteins in the plasma.
Finding identical cholesterol levels but differences in lipoprotein size implied that the numbers of particles in the plasma of the 2 models would be different. Indeed, this was the case. Plasma apo B-100 levels were nearly 4-fold higher in Ldlr Ϫ/Ϫ Apob 100/100 mice than in Apoe Ϫ/Ϫ Apob 100/100 mice. 8 Thus, we had generated 2 new hypercholesterolemic mouse models-both apo B-100-only and both with the same plasma cholesterol level-but with profound differences in lipoprotein sizes and lipoprotein number.
Atherosclerosis Susceptibility in Apoe ؊/؊ Apob 100/100 and Ldlr ؊/؊ Apob 100/100 Mice
We decided to study atherosclerosis susceptibility in Apoe Ϫ/Ϫ Apob 100/100 and Ldlr Ϫ/Ϫ Apob 100/100 mice to obtain insights into the relative atherogenicities of 2 very different lipoprotein pheno-types. 8 For controls, we analyzed Apoe Ϫ/Ϫ and Ldlr Ϫ/Ϫ mice that were homozygous for a wild-type apo B allele (Apoe Ϫ/Ϫ Apob ϩ/ϩ and Ldlr Ϫ/Ϫ Apob ϩ/ϩ mice). All 4 groups of mice (nՆ40 each) were fed a chow diet for 40 weeks. At the 40-week time point, the total plasma cholesterol levels (meanϮSEM) in Apoe Ϫ/Ϫ Apob 100/100 and Ldlr Ϫ/Ϫ Apob 100/100 were virtually identical (334Ϯ12 and 336Ϯ8 mg/dL, respectively). As expected, the total plasma cholesterol levels were much higher in Apoe Ϫ/Ϫ Apob ϩ/ϩ mice (497Ϯ23 mg/dL) and lower in Ldlr Ϫ/Ϫ Apob ϩ/ϩ mice (235Ϯ12 mg/dL).
Computer-assisted morphometric techniques were used to assess the percentage of the aortic surface covered by atherosclerotic lesions at 40 weeks. The results were striking and clear. Mice with larger numbers of small lipoproteins (ie, the Ldlr Ϫ/Ϫ Apob 100/100 mice) had far more atherosclerosis than did mice with smaller numbers of large lipoproteins (ie, the Apoe Ϫ/Ϫ Apob 100/100 mice) 8 (the Table) . Of note, the Apoe Ϫ/Ϫ Apob ϩ/ϩ mice actually had only about one half as much atherosclerosis as the Ldlr Ϫ/Ϫ Apob 100/100 mice, despite having far higher plasma cholesterol levels. As expected, the Ldlr Ϫ/Ϫ Apob ϩ/ϩ mice had minimal atherosclerosis.
We also measured the amount of free and esterified cholesterol in the aortas and the rate of aortic DNA synthesis. The Ldlr Ϫ/Ϫ Apob 100/100 mice accumulated far more cholesterol in their aortas than did the Apoe Ϫ/Ϫ Apob 100/100 mice (the Tabl1), despite virtually identical plasma cholesterol levels. 8 We found a strong, positive correlation between lesion size, measured morphometrically, and the aortic content of esterified cholesterol both for all of the mice in the study (rϭ0.858, PϽ0.0001) and for most of the subgroups (Apoe Ϫ/Ϫ Apob ϩ/ϩ : rϭ0.719, PϽ0.0001; Apoe Ϫ/Ϫ Apob 100/100 : rϭ0.705, PϽ0.0001; and Ldlr Ϫ/Ϫ Apob 100/100 : rϭ0.734, PϽ0.0001). These results suggest that it would be reasonable to substitute lipid measurements for morphometric approaches in many mouse atherosclerosis experiments.
To measure DNA synthesis within the aortas, we used stable-isotope incorporation/mass spectrometry. In line with the morphometric results and the cholesterol measurements, aortic DNA synthesis in the Ldlr Ϫ/Ϫ Apob 100/100 mice was almost twice as high as in Apoe Ϫ/Ϫ Apob 100/100 mice 8 (Table 1 ). However, the correlations between aortic DNA synthesis and the other measures of atherosclerosis were relatively low (rϭ0.574, PϽ0.0001 for DNA synthesis vs morphometric data; rϭ0.469, PϽ0.0001 for DNA synthesis vs aortic cholesterol esters). The correlation coefficients were far lower (generally 0.2 to 0.4) when the data from single genotypes were considered. We doubt that the weak correlations can be attributed to inaccuracy in the DNA synthesis rate, given the precision of mass spectrometry. One possible explanation for the low correlation coefficients is that we measured DNA synthesis in the whole aorta, thereby contaminating our measurements with populations of cells that were not directly involved in the atherosclerotic process. Alternatively, cellular proliferation and the accumulation of lipid-rich lesions may not be tightly linked at a mechanistic level, either temporally or spatially. We suspect that these issues could be sorted out with additional studies of aortic DNA synthesis in mice.
Measurements of Atherosclerosis in Apoe

Are the Differences in Atherosclerosis Susceptibility Explained by Differences in Lipoprotein Size and Number?
The Ldlr Ϫ/Ϫ Apob 100/100 mice were far more susceptible to atherosclerosis than Apoe Ϫ/Ϫ Apob 100/100 mice, despite virtually identical plasma cholesterol levels. How should this result be interpreted? The likely explanation is the dramatic differences in the lipoprotein phenotype, with large numbers of small lipoproteins (the phenotype in Ldlr Ϫ/Ϫ Apob 100/100 mice) being more atherogenic than lower numbers of large lipoproteins (the phenotype in Apoe Ϫ/Ϫ Apob 100/100 mice). In Figure 2 , we plotted the total plasma cholesterol levels and atherosclerotic lesions for all 4 groups of mice, 2 of which had a preponderance of small lipoproteins (the LDL receptor-deficient mice) and 2 with a preponderance of large lipoproteins (the apo E-deficient mice). Plotted in this fashion, the data naturally suggest the possibility of a distinct "plasma cholesterol vs atherosclerosis" relationship for small and large lipoproteins. When most of the lipoproteins are in the LDL size range, increasing the plasma cholesterol levels from Ϸ200 to Ϸ300 mg/dL caused a Ϸ30-fold increase in atherosclerotic lesions. In contrast, when most of the cholesterol was in the VLDL fraction, increasing the plasma cholesterol levels from 300 to 450 mg/dL increased the extent of atherosclerosis by Ͻ2-fold.
It is worthwhile emphasizing that the lipoproteins in the Apoe Ϫ/Ϫ Apob 100/100 mice were extremely large; more than half of the cholesterol was contained in lipoproteins with diameters Ͼ70 nm. Previous studies have suggested that "giant" lipoproteins are less able to penetrate the arterial wall than are smaller lipoproteins. 11 Thus, the cholesterol levels within the arterial walls of Apoe Ϫ/Ϫ Apob 100/100 mice may have been much lower than in the Ldlr Ϫ/Ϫ Apob 100/100 mice. Lipoprotein size could also affect the propensity of lipoproteins to bind to the arterial wall matrix. Changes in particle size clearly affect the conformation of apo B-100 on the surface of lipoproteins 12 ; perhaps the domains of apo B-100 that bind to the arterial wall are "hidden" in large VLDL but exposed in LDL.
Differences in lipoprotein size and number provide the most obvious explanation for the differences in atherosclerosis in Ldlr Ϫ/Ϫ Apob 100/100 and Apoe Ϫ/Ϫ Apob 100/100 mice, but we cannot exclude other possibilities. For example, the half-life of lipoproteins in plasma is almost certainly longer in Ldlr Ϫ/Ϫ Apob 100/100 mice than in Apoe Ϫ/Ϫ Apob 100/100 mice. That difference could have secondary effects on susceptibility to oxidation and thus, on the recruitment and retention of macrophages in the arterial wall. Also, we suspect that most of the lipoproteins in Ldlr Ϫ/Ϫ Apob 100/100 mice are derived from the liver and that a large percentage originate in the intestine in Apoe Ϫ/Ϫ Apob 100/100 mice. Another difference is that the lipoproteins from Ldlr Ϫ/Ϫ Apob 100/100 mice contain apo E, whereas those from Apoe Ϫ/Ϫ Apob 100/100 mice do not. That compositional difference was accompanied by changes in the levels of other apolipoproteins, in both the VLDL and HDL. Perhaps those compositional differences affected lipoprotein retention within the arterial wall or the efficiency of reverse cholesterol transport. Finally, one could postulate that the absence of apo E synthesis within the arterial wall of Apoe Ϫ/Ϫ Apob 100/100 mice was antiatherogenic or that the absence of LDL receptor expression in the arteries of Ldlr Ϫ/Ϫ Apob 100/100 mice was proatherogenic. 8, [13] [14] [15] 
Implications for Studies of Atherogenesis in Mice
The Ldlr Ϫ/Ϫ Apob 100/100 mice developed extensive atherosclerosis on a chow diet-far more than the apo E-deficient mice. Should the Ldlr Ϫ/Ϫ Apob 100/100 mice become the preferred model for investigating atherosclerosis? Not necessarily. The choice of an animal model obviously must depend on the hypothesis to be tested. For some studies, the Ldlr Ϫ/Ϫ Apob 100/100 mice might be ideal (eg, testing hypolipidemic or other antiatherosclerosis drugs). On the other hand, the use of these animals for genetic experiments might be inconvenient, because adding additional transgenes or knockout alleles would require onerous, timeconsuming, and costly breeding. We do, however, believe that the differences in atherosclerosis susceptibility in Ldlr Ϫ/Ϫ Apob 100/100 and Apoe Ϫ/Ϫ Apob ϩ/ϩ mice should heighten awareness about the potential influence of lipoprotein size and number on atherosclerosis, independent of the plasma cholesterol levels. For some types of studies, this effect might influence the interpretation of experimental results.
It is important to emphasize that "adding Apob 100 alleles" to Ldlr Ϫ/Ϫ mice is not the only way to increase their LDL cholesterol levels. 16 In collaboration with Powell-Braxton and Davidson, we produced Apobec1-deficient mice, 17 which lack the ability to edit apo B mRNA and therefore, synthesize exclusively apo B-100. Ldlr Ϫ/Ϫ Apobec1 Ϫ/Ϫ mice, like Ldlr Ϫ/Ϫ Apob 100/100 mice, have high plasma apo B-100 and LDL cholesterol levels and develop severe atherosclerosis. 18 The initial description of Ldlr Ϫ/Ϫ Apobec1 Ϫ/Ϫ mice 18 suggested that they might have higher plasma cholesterol levels than Ldlr Ϫ/Ϫ Apob 100/100 mice. However, those data were obtained in mice housed in different facilities and consuming different diets. We are skeptical that those differences would hold up in side-by-side comparisons because we were unable to detect differences in the plasma apo B-100 levels of chow-fed Apob 100/100 and Apobec1 Ϫ/Ϫ 19, 21 In addition to high LDL cholesterol levels, the Ldlr Ϫ/Ϫ HuBTg ϩ/ϩ mice had moderately high VLDL levels and high levels of triglycerides in the LDL fraction. The explanation for the hypertriglyceridemia in those animals is not clear. 16
Prospects for a Diet-Independent Model for Reversing Hypercholesterolemia
A goal of many investigators is to use mouse models to understand how hypercholesterolemia changes the biology of the arterial wall. To define how hypercholesterolemia changes arterial wall gene expression, it would be useful to have access to a hypercholesterolemic mouse model in which one could "turn off" the hypercholesterolemia and reverse the susceptibility to atherosclerosis. One could then examine the time course for atherosclerosis regression and changes in arterial wall gene expression. Such a model would be particularly valuable if the hypercholesterolemia could be reversed without changing either the diet or the nutritional status of the animal. Microsomal triglyceride transfer protein is required for the secretion of apo B-100 -containing lipoproteins from the liver. 22 In a recent study, we produced mice that carried the inducible Mx1-Cre transgene 23 and were homozygous for a conditional ("floxed") allele of Mttp, the gene for microsomal triglyceride transfer protein. 24 After induction of the Cre transgene with a synthetic double-stranded RNA, high levels of recombination occurred in the liver, inactivating Mttp and causing apo B-100 levels to fall by Ͼ90%. Intestinal function and the nutritional status of the mice were unaffected.
We have recently bred Ldlr Ϫ/Ϫ Apob 100/100 mice that also harbor the Mx1-Cre transgene and the floxed Mttp alleles. Preliminary studies suggest that the hypercholesterolemia in those mice can be eliminated by inducing expression of the Cre transgene. This model should be useful for studying plaque regression and for defining how hypercholesterolemia changes arterial wall gene expression.
